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A B S T R A C T
Studies in mice undergoing acute Trypanosoma cruzi infection and patients with Chagas disease, led to identify
several immune-neuroendocrine disturbances and metabolic disorders. Here, we review relevant findings con-
cerning such abnormalities and discuss their possible influence on disease physiopathology.
1. Introduction
The interactions between the immune and neuroendocrine systems,
as well as metabolic pathways, play central roles during acute or
chronic infectious diseases. Upon exposure to infectious stress, these
major systems act in an integrated fashion to promote both pathogen
control and host protection, as well as avoiding tissue damage and
hence contributing to homeostasis recovery. Such physiologic and ap-
propriate anti-stress response is sustained for a reasonable period being
turned off once homeostasis is achieved [1].
In contrast, prolonged stress leads to a chronic and not always
beneficial situation [2], in which the immune, neuroendocrine and
metabolic communication becomes abnormal or disrupted. As such, in a
wide range of acute and chronic infectious diseases, the anti-infectious
immune response coexists with endocrine and metabolic alterations
[3,4].
Particularly, in the context of experimental and human Chagas
disease, diverse alterations from the immune-neuroendocrine systems
and metabolic disorders have become evident in the last years. Here, we
review relevant findings concerning such abnormalities during T. cruzi
infection and discuss their possible influence on disease physio-
pathology.
The clinical course of Chagas disease comprises both an acute and a
chronic phase. Depending on the route through which the infection is
established (vectorial, congenital, transfusional, oral, transplant, or la-
boratory accidents), the acute phase may range from an asymptomatic
form (mainly in vectorial cases) to severe disease manifestations, in-
cluding acute myocarditis, meningoencephalitis, and sudden death. In
general, the acute stage self-resolves 2–3months later, and individuals
remain chronically infected. Once the chronic stage is established,
nearly 30% of infected people progress to the symptomatic chronic
disease (myocardial or gastrointestinal compromise), with the re-
maining ones persisting in a symptomless chronic stage, formerly called
indeterminate form [5,6].
Reasons accounting for such a diverse spectrum of clinical outcomes
are still debatable. As to the chronic form, the current view points out to
inflammation as the main determinant of progression, in coexistence
with other well-known potential contributory factors like parasite
persistence, strain virulence, autoimmune reactions and tissue tropism
[2,7–9]. There is a reason to believe, however, that the disturbed
neuroendocrine and metabolic responses are also likely to exert a det-
rimental influence on disease course [10].
In a broad sense, the integrated response from the host against in-
fectious agents involves not only the generation of an inflammatory
response addressed to pathogen elimination but also the redirection of
energy supply, promotion of tissue repair and finally homeostasis re-
covery. When this integrated response fails to do so, it acquires a new
status and may become detrimental. In this way, the same components
taking part in the establishment and regulation of the inflammatory
response (cytokines, counteracting elements like regulatory T cells,
glucocorticoids, and neurotransmitters) may also mediate harmful ef-
fects. Many disturbances identified during T. cruzi infection in both
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humans and experimental models, fit well with this conceptual frame-
work [10,11].
A crucial factor in the signaling networks involving the immune and
neuroendocrine systems as well as energy metabolism is the fact that
cytokines, hormones, neuropeptides, neurotransmitters, and even me-
tabolic factors are common elements from lymphoid, endocrine, neural
or specialized metabolic tissues, allowing permanent sensing of in-
trinsic and extrinsic signals [12,13]. A classic example of this interac-
tion is well represented by the stress response, which is mainly driven
by neural inputs, although proinflammatory cytokines are particularly
involved in its activation. As a result, cortisol (in humans) or corti-
costerone (in rodents) are released by the adrenal glands, well known
for inducing metabolic effects like glucose availability, promotion of
antibody production and downregulating immune influences, among
others [12]. In the same way, gonadal cells express receptors for cy-
tokines and neural factors, whereas immune cells can be influenced by
sex hormones. In turn, lymphoid organs and endocrine glands are in-
nervated and exhibit receptors for neural factors, rendering them re-
sponsive to neurotransmitters and neuropeptides [12].Within this reg-
ulatory loop, the adipose tissue, can release not only hormones but also
cytokines and adipocytokines [14].While being extensively innervated
by sympathetic fibers, locally secreted factors from the adipose tissue
may reciprocally affect the functioning of sensory nerve fibers [15].
2. Changes in the physiology of the hypothalamus-pituitary-
adrenal (HPA) axis during T. cruzi infection
Before addressing this issue, it is worth discussing the main phy-
siological and molecular basis of the HPA axis. Usually, proin-
flammatory cytokines released by activated immune cells, not only
initiate immune reactions but also gain access to the central nervous
system through the systemic route. Cytokines like IL-1β, TNF-α, IL-6,
and IFN-γ act at the paraventricular nucleus of the hypothalamus to
release corticotropin-releasing hormone (CRH). Via the hypophyseal-
portal circulation, CRH reaches the anterior pituitary to stimulate the
release of adrenocorticotropic hormone (ACTH) into the circulatory
system resulting in the secretion of glucocorticoids (GC) from the
adrenal gland cortex [16].In addition to acting on central structures,
proinflammatory cytokines were recently found to directly modulate
GC synthesis at the adrenal level [17].
Endogenously synthesized GC displays a plethora of beneficial ef-
fects, especially, as a regulator of inflammatory responses [18]. When
cytokines are synthesized in excessive amounts, GC suppresses their
production as well as the leukocyte chemotaxis and peripheral cellular
traffic [19,20]. GC also promotes a Th1→ Th2 bias to prevent excessive
cellular responses and hence avoiding the in situ deleterious effects of
activated macrophages and Th1 lymphocytes [21].The relevance of the
anti-inflammatory effects of GC during an infectious process is sub-
stantial, given that the deprivation of steroid activity through adrena-
lectomy increases fever and mortality [22]. In essence, HPA activation
during the inflammatory response constitutes a very important pro-
tective mechanism to limit the immune-mediated damage [18].
In parallel to the production of GC, HPA axis activation also leads to
the release of DHEA, another adrenal steroid with important im-
munoregulatory effects. DHEA seems to act in synergy with the anti-
inflammatory effect of GC given the well-known anti-phlogotic effects
of this androgen [23]. Al the same time, DHEA stimulates cellular re-
sponses for which it counteracts the inhibitory effect of GC on IL-2
synthesis [24]. Disrupted activation of the HPA axis in humans but not
in rodents [25], is also characterized by decreased concentrations of
DHEA or their metabolite DHEA-sulfate (DHEAs) leading to an un-
balanced cortisol/DHEA or cortisol/DHEAs ratio [26–28].
Studies analyzing neuroendocrine and metabolic responses during
the acute phase of human Chagas disease are scarce. Vectorial and
congenital infections, mainly occurring in children, are usually difficult
to identify, rendering the study of immune, neuroendocrine and
metabolic parameters in them quite challenging. Additionally, the ex-
pected results of these studies may be influenced by diverse variables
like age, nutritional factors, environmental conditions, etc. However,
the symptomatic cases of oral Chagas disease represent an attractive
field for future studies addressed to synchronically evaluate the activity
of this complex immune-neuroendocrine network and how the in-
tegrative response may influence disease course. Currently, our
knowledge about this type of interactions during the acute stage comes
from animal models of T. cruzi infection, suitable for evaluating and
manipulate multiple factors at the same time. On the other hand, data
about immune-neuroendocrine and metabolic changes during the
chronic phase mostly came from studies in human Chagas disease.
Therefore, here we will concentrate on evidence obtained from animal
models of acute infection, and individuals with chronic Chagas disease.
2.1. HPA axis in murine models of acute T. cruzi infection
During the last two decades, our laboratory has provided convincing
evidence that cytokines released by the immune system after the in-
fection with the Tulahuén strain of T. cruzi have profound effects on the
HPA axis, and hence affecting disease course. Acute T. cruzi infection
induces the release of IL-1β, IL-6, TNF-α, and IFN-γ, able to elicit a 10-
fold increase in corticosterone blood levels [29–31]. Comparative stu-
dies between susceptible C57BL/6 (Th1-biased) and resistant BALB/c
(Th2-biased) male mice also indicated that disease susceptibility de-
pends on the appropriate timing and extent to which the HPA axis is
activated, rather than a difference in parasitemias. In this sense, the
higher basal levels of corticosterone followed by a further early increase
in corticosterone levels in infected BALB/c mice, is likely to account for
the increased proportion of surviving BALB/c mice from acute infection
[30,32]. In addition, infected BALB/c mice developed an earlier re-
sponse of T. cruzi-specific IgG antibodies compared to C57BL/6 [33].
Since IL-1β is the most potent cytokine in terms of HPA axis activation
[34], the earlier and higher circulating levels of IL-1β seen in BALB/c
infected mice may be indicative of a more effective activity of this
neuroendocrine axis [29]. Our studies revealed that appropriate HPA
axis activation is clearly influential in terms of disease course and
susceptibility [30,31] since GC depletion leads to a dramatical increase
of circulating proinflammatory cytokines accompanied by an ac-
celerated death of T. cruzi-infected mice, rendering the BALB/c group
100% susceptible. Furthermore, in accordance with an expected GC-
driven Th2 response, infected BALB/c mice exhibited early increased
levels of T. cruzi specific-IgG antibodies compared to C57BL/6 coun-
terparts [33]. The essential features of HPA axis activation in both re-
sistant and susceptible models of acute T. cruzi infection in male mice
are summarized in Fig. 1A and B. Interestingly, C57BL/6 mice showed a
clear sexual dimorphism in terms of susceptibility to infection. While
30–50% of females survived from the acute phase of infection, 100% of
infected males succumbed. Although sexual hormones appear to have a
protective role against the parasite, it was clear that females have a
two-fold increase of baseline GC levels respect to males [35].
TNF-α is essential to protect against T. cruzi by enhancing the try-
panocidal activity of IFN-γ-activated macrophages. However, a dysre-
gulated production of TNF-α can be at the same time detrimental, be-
cause this cytokine also participates in tissue injury. Coincidentally,
C57BL/6 susceptibility to T. cruzi infection was linked to an ex-
acerbated TNF-α production, causing tissue damage and diverse toxic
effects [33,36,37]. As shown schematically in Fig. 1B and C, the abo-
lition of TNF signaling, by using C57BL/6 mice genetically deficient for
both TNF-α receptors (TNFR1/2 KO), increased blood parasites and
myocardial parasite nests. Infected TNFR1/2 KO mice had even higher
concentrations of IL-1β than C57BL/6 wild type, as did IL-6, and IFN-γ,
which may explain the pronounced stimulation of the HPA axis showed
by this group in terms of GC production. Nevertheless, GC seems to be
ineffective in cope with excessive inflammation, since TNFR1/2 KO in-
fected mice developed a marked disease severity, i.e., cachexia, and
F.B. González, et al. BBA - Molecular Basis of Disease 1866 (2020) 165642
2
early death [30]. Similar but less significant changes were also observed
in C57BL/6 mice genetically deficient for each TNF receptor, being
more pronounced in TNFR1 KO mice than TNF-R2 KO, highlighting the
importance of TNF-R1 in the control of T. cruzi infection [30].
One study showed that HPA axis activation during T. cruzi infection
in mice lacking adaptative immunity turns out to by excessive. In fact,
experiments by using C57BL/6 RAG-1-defective mice revealed an ear-
lier and robust increased of GC amounts upon T. cruzi-infection when
compared to wild type counterparts. Such overreaction may be the
result of an innate exacerbated production of IL-1β and IL-6; likely
linked to MyD88/TRIF-dependent mechanisms, activated through Toll-
like-2, TLR-4 and TLR-9 because of an excessive T. cruzi-derived
PAMPs, given the 20-fold further increased parasitemia seen in RAG-1
infected mice [38].
More recent studies additionally indicated a hormonal signal dis-
connection between pituitary and adrenal glands towards the end of
acute infection, since corticosterone continued to increase, whereas
ACTH returned to basal levels [39,40]. Interestingly, studies by in-
fecting a murine ACTH-producing cell line (atT-20) with T. cruzi, led to
a profound reduction of ACTH release and the expression of its hor-
mone precursor proopiomelanocortin (POMC) if compared to unin-
fected cells. These atT-20 infected cells also released high IL-6 amounts,
although its stimulating effect on POMC synthesis seemed to be in-
hibited by an increase in SOCS3 -a suppressor of cytokine signaling
molecule- [39]. In an additional study carried out in the same cells, an
increase in the inhibitor of STAT-3 (called PIAS3) was observed. PIAS3
can bind STAT3 and blocks ACTH-transcriptionally activity, suggesting
a possible direct role for PIAS3 in the ACTH decay [39].
Data from human sepsis or endotoxemia models indicate that GC
increase decoupled from ACTH may be related to the presence of
proinflammatory mediators released at the adrenal level. Resident im-
mune cells or even adrenocortical cells can be a potential source of
cytokines [41].Within this setting, T. cruzi infected mice, not only
showed increased levels of TNF-α, IL-1β, and IL-6 in circulation but also
intra-adrenally, implying that a local inflammatory microenvironment
may account for the maintenance of the high GC output [40,42,43]. In
parallel, GC synthesis can also be modulated locally by prostaglandin
E2 and nitric oxide [44]. Some studies showed that pathogen antigens
can trigger intra-adrenally the GC synthesis through the engagement of
TLR-2 and TLR-4, as well. In this sense, TLR-2-deficient mice, have
impaired adrenal corticosterone even in the presence of augmented
ACTH levels [45]. The presence of parasite-derived antigens may pro-
mote this local inflammatory response and trigger the synthesis and
secretion of GC. Even, during T. cruzi infection, the intra-adrenal
synthesis of inflammatory cytokines may be triggered through TLR-2
since trypomastigote-derived glycosylphosphatidylinositol anchors are
potent TRL-2 agonists [46].
2.2. HPA axis in human chronic Chagas disease
Our studies in patients with chronic Chagas disease demonstrated
that a broad range of pro-inflammatory cytokines is produced during
this stage, preferably in symptomatic cases. This inflammatory milieu
may affect endocrine mechanisms, further implied in the disease course
[47]. HPA axis abnormalities have been also recognized in human
chronic Chagas disease. For instance, patients with heart affectation,
the commonest dysfunction, display a high cortisol/DHEAs ratio, due to
a profound diminution of DHEAs in presence of nearly preserved
amounts of GC [47,48].Usually, DHEA fall with aging, but in chagasic
patients, the diminution of this hormone is not related to their age
status. Such imbalance, also observed in other forms of acute or chronic
illnesses, is probably related to the rise of circulating cytokines [27].
Interestingly, chronic chagasic patients without apparent pathology
showed lower levels of pro-inflammatory cytokines and a more ba-
lanced GC/DHEAs relationship [47].The mechanisms likely to explain
such differences are not completely known, although variations in the
circulating levels of diverse immune-endocrine mediators seem to be
involved. Whatever the case, disturbances in cortisol/DHEA ratio seem
to be detrimental to the host due to a deficient control of inflammation
and the ensuing development of tissue injury [49]. Interestingly, ma-
laria or human schistosomiasis, which showed a less torpid evolution
than Chagas disease, are associated with increased levels of DHEA
[50–52], suggesting a protective role for this hormone in such para-
sitosis. At the experimental level, treatment with DHEA improved the
immune response during T. cruzi infection [53,54]; although the study
did not analyze whether DHEA levels correlated with cytokines acti-
vating the HPA axis.
Focusing again on the chronic human disease scenario, the adverse
endocrine context (i.e., the increased GC/DHEA ratio), along with the
large number of antigenic constituents displayed by T. cruzi may favor
the activation of a polyclonal immune response and the consequent risk
of autoreactivity [55]. While the autoimmune basis of Chagas disease is
still debatable, there is a reason to believe that suppression or an ad-
verse adrenal counter-regulatory mechanism may act as a permissive
factor for the development of autoimmune phenomena; for which stu-
dies concerning immune-endocrine imbalance and T. cruzi-driven au-
toreactivity are clearly needed.
3. Other hormones produced by the anterior pituitary are also
altered in both experimental and human Chagas disease
Anterior pituitary hormones, including ACTH, growth hormone
(GH), prolactin (PRL), thyroid-stimulating hormone (TSH), and the
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Fig. 1. Comparative representation of cytokine and corticosterone production,
parasitemia and survival between different strain of mice acutely infected with
T. cruzi.
Illustrative representation of variations in different parameters during T. cruzi
infection in: A) resistant BALB/c, B) susceptible C57BL/6, and C) C57BL/6 mice
deficient in both tumor necrosis factor receptors (C57BL/6-TNFR1/2KO).
Resistance to T. cruzi infection in BALB/c mice is associated to a more rapid
increase in endogenous corticosterone levels and an early interleukin (IL)-1β
production. Increased mortality in C57BL/6 mice is related to an excessive
production of tumor necrosis factor-alfa (TNF-α). Blocking TNF-α signaling in
C57BL/6 mice accelerates lethality and increases parasitemia, corticosterone
and IL-β production. Corticosterone depletion by adrenalectomy prior to in-
fection, renders BALB/c mice susceptible and shortens the survival time of
C57BL/6 mice. eGC: survival in mice with endogenous corticosterone produc-
tion. GC(−): survival in adrenalectomized mice.
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can also modulate the immune response, whereas cytokines can equally
influence their production [12]. GH and PRL which are regarded as
stress hormones, appear increased during stressful conditions, as does
GC, because of the direct pituitary action of pro-inflammatory cyto-
kines. Interestingly, PRL and GH increase exert enhancing effects on the
immune response, counterbalancing the downregulating influences of
GC [56].
Data from experimental and human studies showed that PRL- and
GH-physiological responses are altered during T. cruzi infection; pos-
sibly related to the demonstration that T. cruzi can infect the pituitary
[39,57].In fact, in vitro T. cruzi infection of GH-/PRL-secreting GH3
cells, leads to a diminution of both GH and PRL secretion [58]. Moving
to the in vivo scenario, acutely T. cruzi infected mice showed a reduc-
tion in circulating PRL levels [59], whereas PRL supplementation in rats
undergoing this protozoan infection led to a better parasite control
coupled to macrophage activation, nitric oxide production and T cell
proliferation [60]. Thus, the decrease in PRL production evidenced in
mice after T. cruzi infection could synergize the immunosuppressive
role of GC.
PRL has a protective effect on the cardiovascular system, and its
physiological raise (as seen during lactation), may stimulate the JAK-
STAT pathway involved in cardiomyocyte hypertrophy [61]. When
achieving levels above the physiological ones PRL may alter cardiac
metabolism and microvasculature [62], for which increased PRL levels
may favor physiopathological events involved in the development of
cardiac damage being in line with the fact that patients with CCM
tended to display increased PRL amounts [47].
GH exerts both immune-stimulant and metabolic effects. GH direct
metabolic effects include up-regulation of insulin secretion, lipolysis,
and gluconeogenesis. In turn, effects on glucose energy and protein
metabolism are indirectly exerted via the Insulin-like Growth Factor 1
(IGF-I), constituting the GH/IGF-1 axis [63].Theoretically, GH levels
may be increased during a T. cruzi-driven stress response, but evidence
in this regard is lacking. Studies in acutely T. cruzi-infected rats showed
that GH administration improves parasite control by enhancing TNF-α,
nitric oxide and IFN-γ synthesis [64], implying a protective role of GH
during the acute stage of infection. In the context of human Chagas
disease, data from chronically infected individuals indicate a remark-
able systemic increase of GH levels in patients with CCM along with an
increased GH/IGF-1 ratio, compatible with an imbalance in the soma-
totropic axis [47]. Despite that, individuals with CCM also display a
poor release of GH in response to glucose or insulin challenge compared
to healthy subjects, suggesting some deficiency in GH reserve [65]. GH
may act directly or indirectly as a modulator of myocardial structure
through myocyte receptors for both GH and IGF-1. Therefore, increased
GH levels seen in the CCM group may imply a facilitating role of this
hormone on the immune mechanisms involved in myocardial damage,
particularly the inflammatory component which is a major determinant
for disease progression.
Studies carried out many years ago, showed that acutely T. cruzi-
infected mice had thyroid hyperplasia, even more in females, along
with an enhanced thyroid uptake of radioactive iodine. Such findings
were interpreted as being due to thyroid parasite infection, an indirect
consequence of stress response, or both [66]. Turning to the human
counterpart, the seminal work of Carlos Chagas, who described most
disease aspects in the first decade of 1900; classified chronic CD into
cardiac, thyroid, and nervous clinical forms (this one different from the
current neuro-autonomic form). The inclusion of the thyroid form of the
disease was based on clinical features, the association of goiter with
myxedema, and the presence of parasites and inflammatory infiltrates
in thyroids removed from necropsies [67]. Currently, it is no longer
accepted that Chagas disease causes goiter [68], mainly because hy-
pothyroidism is instead due to iodine deficiency which prevails in zones
also endemic for T. cruzi infection [69]. Studies conducted in a group of
patients from endemic areas of Argentina (Santa Fe, Santiago del Es-
tero, and Chaco), indicated that the pituitary-thyroid axis activity
remains virtually unchanged during chronic Chagas disease. In both
asymptomatic and CCM patients, TSH and T4 concentrations fell within
values seen in healthy controls, whereas T3 levels were slightly di-
minished in patients with severe CCM [47].
4. Antagonist effects of GC and PRL on the murine thymic T cell
compartment during T. cruzi infection
Several thymic functions, including T cell development, are phy-
siologically controlled by a variety of hormonal influences [70]. Besides
classical thymic hormones such as thymulin, thymosins, and thymo-
poietin; GH, PRL, and GC are also produced by microenvironmental
thymic cells and thymocytes, exerting local paracrine/autocrine reg-
ulatory actions [70]. This complex neuroendocrine network operating
at the thymic level has been particularly and systematically examined
in the context of the experimental T. cruzi infection.
In general terms, increases in systemic GC levels due to acute or
chronic stress, or their therapeutic administration cause thymus in-
volution since immature thymocytes are particularly sensitive to GC-
induced apoptosis [12]. As showed in Fig. 2, a consistent feature of T.
cruzi infection in mice is the occurrence of thymus atrophy, closely
related to HPA axis activation since GC blockade employing adrena-
lectomy or the administration of the steroid receptor antagonist RU486
prevented from such phenomenon [30,31].The shrinkage of the thymic
gland is the result of massive GC-driven apoptosis of CD4+CD8+
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Fig. 2. Comparative representation of thymic parameters in C57BL/6 mice
acutely infected with T. cruzi.
Schematic representation of changes in thymic parameters recorded in: A)
Infected C57BL/6 wild type mice, B–C) or infected C57BL/6 mice lacking cor-
ticosterone (adrenalectomy) or tumor necrosis factor (TNF)-α signaling (TNF-
R1/2 deficiency). In the wild type mice, the thymic atrophy is characterized by
the loss of CD4+CD8+ double positive (DP) cells and thymic regulatory T cells
(tTregs) along with an increased cellular apoptosis, linked to raised corticos-
terone blood levels. Adrenalectomy (Adx) protects from thymic atrophy,
avoiding DP and tTregs loss. The lack of TNF-α signaling in TNFR1/2KO mice
results in a more severe thymic atrophy compared to wild type mice, together
with a pronounced increase in corticosterone levels.
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CD8+ simple positive thymocytes and CD4+FoxP3+ regulatory T cells
[30,31,71]. Such GC-induced apoptosis of DP cells is exerted through
the activation of caspase-8 and caspase-9, but not caspase-3 [72].
Strikingly, serum increased levels of adrenal-derived GC were paral-
leled by a decrease in their intrathymic contents, implying that the
control of intrathymic GC production during acute T. cruzi infection, is
driven by mechanisms other than those operating at the adrenal level
[59].
PRL has opposing actions to GC on the viability and proliferation of
thymic cells [73]. In thymuses from infected mice, the presence of lo-
cally PRL is heightened, in contrast to their diminished levels seen in
circulation [59]. Moreover, studies during T. cruzi infection showed
that PRL-mediated STAT5 signaling in thymocytes interferes with GC
signaling to inhibit the steroid-induced pro-apoptotic effects, probably
as a compensatory phenomenon [59].
Testosterone is also known to exert a modulatory role on the
thymus. Healthy individuals, recipients of testosterone supplementa-
tion have an increased death of cortical thymocytes, while the ablation
of male gonads increases the thymus size [70]. In the context of ex-
perimental T. cruzi infection, testosterone administration diminishes
thymocyte proliferation, whereas castration significantly increases the
thymus size [74]. Interestingly [75], the role of testosterone seems to be
linked to Trans-sialidase (TS), a virulence factor from T. cruzi involved
in immune evasion [76]. In male mice, the apoptosis of DP cells after TS
administration seems to be partly induced by testosterone [77]. Tes-
tosterone induces thymocyte apoptosis through a caspase-3-dependent
pathway, dissimilar to the one elicited by GC, which activates caspase-8
and caspase-9 pathways [72,77].
In the mouse, TS and TNF-α bind extracellular matrix proteins and
modulates the migratory properties of thymocytes, possibly con-
tributing to the abnormal release of DP thymocytes to the periphery
[78,79]. The detection of IFN-γ+HLA-DR+ activated DP cells in the
blood from patients with CCM, and the IFN-γ+GranzimeB+-DP coun-
terpart seen in infected mice, suggest the existence of thymic alterations
in the selection processes. This raises new questions about the relevance
of such potentially autoreactive cells in the pathogenesis of Chagas
disease, possibly linked to intra-thymic immune-endocrine disturbances
[80,81].
Leptin-deficient signaling in mice was shown to result in chronic
thymic atrophy, pointing out to its role in thymic homeostasis [82].
Coincidently, acutely infected mice developed hypoleptinemia and a
significant decrease in the intrathymic leptin contents when thymus
atrophy became evident. Thymic leptin mRNA remained within the
levels shown by non-infected mice, suggesting post-transcriptional
regulation of its expression. By opposite, mRNA leptin receptor (ObR)
expression was increased in the infected whole thymus, provably ex-
plained by a relative enrichment of the CD4+ and CD8+ simple positive
subpopulations. Since leptin supplementation during an inflammatory
setting restored thymic involution [83,84], it was also evaluated the
effects of recombinant leptin administration on the T. cruzi-induced
thymic atrophy. As expected, in non-infected C57BL/6 mice, leptin
induced a slight thymic hypertrophy. When studying infected mice,
leptin administration resulted in even greater thymic atrophy compared
to non-treated and infected counterparts, suggesting that the over-in-
creased GC response seen in T. cruzi-infected mice are likely to override
the beneficial effects of leptin at the thymic level [85].
The series of thymic alterations seen during T. cruzi infection are
summarized in Fig. 3.
5. Adipose tissue and metabolic disturbances during T. cruzi
infection
5.1. Data from murine models of acute T. cruzi infection
Adipose tissue (AT) is a central organ for the regulation of energy
metabolism capable of influencing the immune response, as well [86].
Adipocytes synthesize adipokines such as adiponectin and leptin which
are influential not only on insulin sensitivity but also on the in-
flammatory response [86,87]. During an infectious process, the high
energy expenditure required to cope with pathogens can cause a re-
markable reduction in the mass of AT, further resulting in metabolic
abnormalities which may worsen disease outcome [88]. The possible
link between the energetic status and the course of T. cruzi infection
was raised by the pioneering work of Tanowitz and collaborators,
documenting that an unfavorable metabolic environment, i.e., diabetes,
aggravated T. cruzi infection [89]. Metabolic alterations during acute
experimental T. cruzi infection have been described by many research
groups. The development of severe hypoglycemia, hypertriglycer-
idemia, the severe loss of AT and body weight are among the most
salient disorders [85,90–93]. In turn, AT is a clear target of T. cruzi
infection, constituting a parasite reservoir during the chronic phase
from mice and humans [91,94]. The mouse acute infection courses with
a profound AT loss, diminution in adipocyte size and increased ex-
pression of proinflammatory cytokines such as IL-6, TNF-α, IL-1β, and
IFN-γ, clearly compatible with an inflammatory environment [90,91].
Proinflammatory cytokines frequently remain elevated within AT even
during chronic infection. This phenomenon is paralleled by a loss of
adipocyte features. In this sense, we and others found a decrease in the
expression of the transcription factor peroxisome proliferator-activated
receptor-gamma (PPAR-γ) during acute severe T. cruzi infection to-
gether with a diminution in the expression of the main enzymes in-
volved in lipolysis and lipogenesis [90,92]. As seen in Fig. 4, PPAR-γ is
a dominant regulator of adipogenesis and highly needed for the main-
tenance of the mature phenotype [95] of adipocytes. PPAR-γ depletion
in mature adipocytes compromises their viability and fat storage be-
cause of the expression loss of the main metabolic enzymes [96,97].
Decreased expression in PPAR-γ in our mouse model is probably due to
the concomitant rise of proinflammatory cytokines like TNF-α. Ac-
companying these findings, there was also a reduction in the expression
of leptin and adiponectin, either in AT or in circulation [85,90,91]. The
impaired adipocyte function together with changes in the adipocyto-
kine profile may favor metabolic alterations and inflammatory reac-
tions seen during acute experimental T. cruzi infection, collectively
contributing to aggravated disease. In general terms, the lower the
adiponectin amounts, the higher glycemic levels, illustrating the in-
sulin-sensitizing activity of this adipocytokine [98–100] Our demon-
stration of a decreased adiposity and severe hypoglycemia during acute
infection, in the presence of a decreased adiponectin expression in AT,
adds another study-stimulating element to the complex network un-
derlying disease pathogenesis. Given that adiponectin deficient mice
are prone to develop myocardial inflammation [101], the relationship
between decreased adiponectin production by AT and the concomitant
proinflammatory status from acutely T. cruzi-infected host may favor
the establishment of myocardial damage.
Also, whereas leptin-deficient mice exhibit hyperphagia, reduced
energy expenditure, diabetes, and obesity [102,103]; the leptin de-
crease from acutely T. cruzi infected mice is paralleled by decreased
food intake, body weight reduction and augmented energy expenditure.
This may be taken to imply a dysregulation of leptin/hypothalamic ObR
circuitry, dissociated from body weight and food intake control during
acute infection [85]. Leptin administration to these mice even worsened
inflammation and failed to normalize metabolic parameters [85].
Within the complex series accompanying acute experimental T.
cruzi infection, severe hypoglycemia is usually present and may con-
stitute a major factor for the fatal course. Hypoglycemia may be the
consequence of a multifactorial process comprising the high energy
demand from activated immune cells, the exacerbated increase of
proinflammatory cytokines, and the reduced food intake seen in the late
phase from acute infection. Deficiencies in the gluconeogenic pathway
may be also envisaged given the liver damage seen during this trypa-
nosomiasis [93]. Strikingly, infected animals did not lose their ability to
handle glucose. Whereas base-line glucose levels from infected mice
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were always below normal values, oral glucose tolerance tests showed a
relatively normal ability to clear ingested glucose [90,91].
In a diet-induced obesity model undergoing T. cruzi infection, most
metabolic alterations appeared improved, although plasmatic apoB100
levels remained significantly increased, suggesting the presence of pro-
atherogenic small and dense LDL particles [104]. Studies in obese mice
subjected to an acute infection showed an insulin resistance state fol-
lowed by chronic hyperglycemia and hypoinsulinemia, compatible with
an infection-related diabetes progression. Collectively, in the obesity
context, T. cruzi infection may be a risk factor for the development of
metabolic disorders like atherosclerosis and diabetes [104].
5.2. Metabolic disturbances in human Chagas disease
In humans, the role that metabolic alterations may have in the pa-
thogenesis and aggravation of CD has not been evaluated in depth. In a
study carried out in Brazil, a higher prevalence of diabetes was ob-
served in women presenting CCM compared to those from the general
population [105]. Infected individuals living in endemic areas show
low body weight (body mass index - BMI - less than 20 [106]), while
infected people that have migrated to urbanized areas presents over-
weight and in some cases obesity [48,107–109]. Such increased BMI is
related to radical changes in their eating habits upon migration, the
city-associated sedentary lifestyle and the educational and socio-eco-
nomic characteristics of these individuals [48,107–109]. In a study

























Fig. 3. Immune, neuroendocrine and metabolic changes associated to thymic atrophy during acute T. cruzi infection.
Preserved thymus may be essential for the development of an effective immune response against T. cruzi, but this organ is severely affected by a dysregulated loop of
cytokine, hormonal and metabolic interactions. The exacerbated systemic production of pro-inflammatory cytokines, mainly interleukin (IL)-1β, tumor necrosis
factor-alfa (TNF-α), IL-6, and interferon-gamma (IFN-γ), mediates the activation of hypothalamus-pituitary-adrenal (HPA) axis. The resulting systemic increase in
glucocorticoids (GC) and the diminution in prolactin (PRL) favors the apoptosis of double positive (DP) cells and the loss of regulatory T cell (Treg). The intrathymic
hormone circuitry shows an inverse modulation that seems to counteract the GC-related systemic deleterious effects. In males, testosterone influences DP cell loss by
caspase activation, while leptin diminution may act as a permissive factor for GC-induced thymic atrophy. An anomalous exit of potentially autoimmune DP cells
would contribute to the thymic atrophy and might have potential implications for the autoimmune component of Chagas disease. The T. cruzi infection-associated
stress might also mediate a sympathetic response on the thymus affecting cellularity, worth exploring.
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had increased insulin and triglycerides levels in circulation, an aug-
mented HOMA-IR index in presence of lower levels of HDL, resembling
a prediabetic situation, which in turn may increase the risk for cardi-
ovascular disease. Overweight and obesity have a strong impact on the
immune response since they are regarded as indicative of chronic low-
grade inflammation states [110,111]. In patients with CCM, we also
found higher levels of IL-6 and changes in TNF-α [48]. Accordingly, an
enhanced inflammatory background resulting from the overweight
present in chagasic patients is likely to add risk factors favoring an early
development of cardiac lesions. Regarding adipokines, results are in-
conclusive. One study reported decreased leptin levels in chagasic pa-
tients with congestive heart failure [112], whereas another report
showed no differences between patients with CCM and controls. Unlike
this, our study in chronically chagasic patients revealed a slight hy-
perleptinemia, particularly in CCM patients [48]. Since patient classi-
fication was different in the three studies, this issue may account for
such reported differences. In line with our findings, leptin levels were
found increased in non-chagasic individuals with chronic heart failure;
this finding being possibly related to the hypertrophic effects of leptin
on cardiomyocytes [113,114]. Since heart enlargement is a common
feature of CCM, a detrimental role of increased leptin levels in this
regard cannot be ruled out [115]. In parallel, augmented leptin levels
may reflect increased inflammation, given its role as an inflammatory
cytokine, particularly in CCM patients. At variance with a study in a
dissimilar subgroup of patients with advanced heart failure showing an
autonomic dysfunction related hyper-adiponectinemia [48,112], adi-
ponectin levels in our series of chagasic patients remained unchanged.
Although not much data is available about metabolic implications of CD
in humans, we can conclude that overweight/obesity and its immune-
metabolic consequences must be addressed when evaluating chagasic
patients, largely because of the increasing presence of this comorbidity
among them.
6. Immunomodulatory role of the autonomic nervous system
during acute T. cruzi infection
There is now convincing evidence that both sympathetic and vagal
parasympathetic branches of the ANS can modulate the immune re-
sponse, mainly by skewing the Th1-response towards a Th2-biased
profile [116–120]. In this sense, neurotransmitters released by sympa-
thetic and parasympathetic nerve endings can bind to their specific
receptors located on the surface of immunocompetent cells initiating
regulatory mechanisms that help to shape the immune response.
It is widely documented that ANS dysfunctions occur in chronic
chagasic patients with cardiac or gastrointestinal involvement, but
whether these derangements are cause or consequence of the pathology
[121,122], it is still a matter of debate, far beyond the scope of this
review.
However, studies carried out after the initial parasite exposure, in
which the development of cardiac or gastrointestinal pathology is quite
unlikely to be established, indicate that the ANS response shapes the
profile of the immune response conditioning disease susceptibility/
outcome from infected mice.
Evidence about the parasympathetic modulation of the anti-T. cruzi
immune response came from studies taking advantage from the vesi-
cular acetylcholine transporter (VAChT). This transporter mediates the
ACh storage inside the synaptic vesicles, allowing the subsequent re-
lease of Ach in the synaptic terminal. C57BL/6 VAChT knockdown mice
infected with the Y strain exhibited a decreased ability to release en-
dogenous ACh linked to a more flourished inflammatory response, di-
minished parasite load and an exacerbated mortality compared to in-
fected wild type mice [123]. The enzyme acetylcholinesterase, which is
involved in the extinction of impulse transmission by rapid hydrolysis
of ACh and their inactivation, leads to ACh accumulation causing hy-
perstimulation of cholinergic pathways. As expected, the administra-
tion of the anti-acetylcholinesterase agent pyridostigmine bromide to T.
cruzi-infected mice favored the parasite growth likely by the restrained
inflammatory response, and hence, tending to increase the mortality






























Fig. 4. Acute T. cruzi infection severely affects the
homeostasis of adipose tissue.
Male mice acutely infected with T. cruzi showed a
progressive and severe reduction in the adipose depots,
mostly in the epididymal adipose tissue. This loss may
be likely linked to immune-endocrine disturbances,
enhanced energy expenditure and parasite-direct ef-
fects. Adipose tissue is infected by the parasite and
amastigote nests are usually observed during the acute
phase, constituting a potential parasite reservoir during
chronic Chagas disease. Atrophy of adipose tissue re-
sults from adipocyte size diminution and parasite-
driven cell destruction. The presence of T. cruzi or their
antigens in the adipose tissue, induce an influx of in-
flammatory cells (mostly macrophages, dendritic cells
and T lymphocytes) and reduced regulatory T cells. The
local secretion of pro-inflammatory cytokines like
tumor necrosis factor-alfa (TNF-α) and interleukin (IL)-
6 seems to be promoted not only by local and in-
filtrating immune cells, but also by adipocytes.
Moreover, infection disrupts both adipocyte catabolic
and anabolic pathways (by down regulating adipogenic
and lipogenic enzymes and adipocytokines) secondary
to peroxisome proliferator-activated receptor gamma
(PPAR-γ) robust downregulation.
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cholinergic pathways during the earlier stages of T. cruzi infection.
Concerning to the immunomodulatory role of the sympathetic
nervous system, a study carried out in β2-adrenergic receptor-deficient
FVB mice infected with the Romildo strain of T. cruzi, showed increased
parasitemias, less pronounced cardiac lesions and improved survival
compared to wild type FVB mice [123]. In a more recent study, T. cruzi-
infected mice whose sympathetic nerve fibers were destroyed pre-
viously by neonatal administration of the neurotoxin 6-hydroxy-do-
pamin, revealed increased parasitemia, raised circulating IL-6 and IFN-γ
levels, dying earlier than non-denervated counterparts. Interestingly,
circulating levels of TNF-α, IL-1β or anti-T. cruzi IgM or IgG2a anti-
bodies from infected mice were unaffected by neonatal denervation
[35]. Strikingly, the acute infection in C57BL/6 male mice induced a
spontaneous fall in the total and relative splenic contents of nora-
drenaline, paralleled by a loss of noradrenergic nerve fibers. Ad-
ditionally, the splenic reduction of noradrenaline was linked to a
marked accumulation of tyrosine (noradrenaline precursor) and lack of
tyrosine hydroxylase immunostaining. While the significance of these
findings is not yet clear, the reduction in the splenic vascular sympa-
thetic tone, may be an attempt to favor splenocyte mobilization to the
blood to cope with the infection [35].
7. Potential mechanisms underlying immune-neuro endocrine
disturbances during T. cruzi infection
Changes in the neuroendocrine activity observed both in experi-
mental models and human Chagas disease can be induced by the anti-
parasite immune response as a part of an immunoregulatory circuit
(i.e., HPA axis activation), in addition to some influence arising from
the functional alterations caused by the disease. Some possible ex-
planations regarding neuroendocrine and metabolic changes include
several and not mutually excluding possibilities (summarized in Fig. 5):
1) A direct effect of parasites on endocrine glands and the autonomic
innervation. The parasites can destroy the cells they have invaded,














Promotion of leukocyte infiltration
Fig. 5. Potential mechanisms underlying neuroendocrine and metabolic disturbances in Chagas disease.
Causes for the T. cruzi infection-associated neuroendocrine and metabolic disturbances include several and not mutually exclusive possibilities. Systemic or local
cytokine abnormalities can enhance or suppress the activation of hormonal axes, by acting at the brain units and/or on peripheral glands. In situ inflammatory
reactions or structural changes like vascular alterations or an enhanced deposition of extracellular matrix (ECM) molecules in the endocrine microenvironment may
also lead to endocrine or metabolic dysfunctions.
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2) Variations in the systemic or local levels of cytokines, which can act
on endocrine glands to enhance or suppress their specific hormonal
function. The presence of parasite or their antigens in glands favors
the influx of inflammatory cells and hence, the local production of
inflammatory cytokines.
3) In situ inflammatory reactions, structural changes, vascular altera-
tions or a greater deposition of the extracellular matrix in the mi-
croenvironment of endocrine glands perpetuates inflammation by
promoting cytokine deposition, modulating leukocyte influx, che-
motaxis, and the activation and survival of infiltrating immune cells.
These changes able to induce a transient dysfunction.
Concerning the presence of T. cruzi at the neuroendocrine tissues,
adrenal amastigote nests were observed in acutely infected mice, while
T. cruzi kDNA and parasite antigens were detected in both the adrenal
and pituitary glands [124–127]. Furthermore, in patients with acute
infection, nests of amastigotes were found in the ovary, testis, thyroid,
and cells from the nervous system [128]. Moreover, T. cruzi infection
causes structural and inflammatory changes in neuroendocrine organs,
like an increase in the deposition of the extracellular matrix, vascular
stasis, and infiltration of macrophages and T cells [129].The extra-
cellular matrix proteins participate in cellular traffic, and their de-
position is enhanced by cytokines, for which an influx of inflammatory
cells into the endocrine glands may be promoted. Furthermore, extra-
cellular matrix molecules may bind diverse T. cruzi-derived antigens
and pro-inflammatory cytokines, thus contributing to a protracted in-
flammation [79,130].







































Fig. 6. Immune, neuroendocrine and metabolic changes associated to experimental acute T. cruzi infection.
Schematic illustration showing the main immune-neuroendocrine disturbances and metabolic disorders seen during acute T. cruzi infection in mice. Note that
parasites or their antigens have been detected in different organs and tissues from the three systems. The center of the graph (with blue background) points to the
main alterations from different immune-neuroendocrine and metabolic mediators during this stage, while systemic and clinical repercussions are mostly indicated in
the periphery (border, edge) of the representation (in white background). ACTH: adrenocorticotropic hormone; CRH: corticotropin releasing hormone; GC: gluco-
corticoids; GH: growth hormone; INF-γ: interferon gamma; IL-1: interleukin 1 beta; IL-6: interleukin 6; IL-10: interleukin 10; ObR: leptin receptor. PPAR-γ: per-
oxisome proliferator-activated receptor gamma; PRL: prolactin; TNF-α: tumor necrosis factor alfa; Tregs Foxp3+: regulatory T cells expressing the transcription factor
FoxP3. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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in this sense, T. cruzi can recognize extracellular matrix proteins like
laminin or fibronectin to invade diverse cells [131].Coincidently, an
increase in the deposition of both extracellular matrix protein was ob-
served in central areas of the brain, particularly in the hypothalamus, as
well as pituitary and adrenal glands, accompanied by an accumulation
of local inflammatory infiltrates and presence of parasites or their ki-
netoplastid DNA [32]. Likewise, pituitary dysfunction is also observed
in animals infected with T. congolense, whereas alterations in the mi-
crovasculature of the gland, greater deposition of extracellular matrix
and presence of parasites in situ were found [132]. Data from viral
infections suggest that neural disorders may be related to a remodeling
of the extracellular matrix in the hypothalamus and other brain areas,
caused by an imbalance of enzymes involved in their synthesis and
degradation. Another possible mechanism of inflammation at the neu-
roendocrine level was related to the existence of autoimmunity. In this
regard, it is worth noting that both human and experimental CD is
characterized by cellular and humoral autoreactivity towards nerve
structures [133]. Overall, these findings indicate that alterations in the
content of the extracellular matrix, coupled with greater tissue in-
flammation and autoreactivity, may play a role in the neuroendocrine
dysfunction seen in this trypanosomiasis.
8. Final comments
Studies reviewed here support the view that proinflammatory cy-





























Fig. 7. Immune, neuroendocrine and metabolic changes associated to human chronic Chagas disease.
Schematic illustration showing the main immune-neuroendocrine disturbances and metabolic disorders detected in patients with symptomatic human chronic Chagas
disease. Note that parasites or their antigens have been detected in different organs and tissues of the three systems. The center of the graph (with blue background)
points to the main alterations from different immune-neuroendocrine and metabolic mediators during this stage, while systemic and clinical repercussions are
indicated in the outer area of the graph (in white background). ANS: autonomic nervous system; BMI: body mass index; DHEAs: dehydroepiandrosterone sulfate; GC:
glucocorticoids; GH: growth hormone; HPA axis: hypothalamus-pituitary-adrenal axis; HOMA-IR: model assessment of insulin resistance; INF-γ: interferon gamma;
IL-1: interleukin 1 beta; IL-6: interleukin 6; IL-10: interleukin 10; IGF-1: insulin growth factor 1; PPAR-γ: peroxisome proliferator-activated receptor gamma; PRL:
prolactin; TNF-α: tumor necrosis factor alfa; Tregs Foxp3+: regulatory T cells expressing the transcription factor FoxP3. (For interpretation of the references to color
in this figure legend, the reader is referred to the web version of this article.)
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disturbances observed in Chagas disease, highlighting the pathological
consequences from the neuro-immune-endocrine and metabolic inter-
actions required to mount a defensive reaction against T. cruzi. A
schematic and integrative representation of those changes is summar-
ized in Figs. 6 and 7, showing the main abnormalities observed in acute
models of T. cruzi infection and in the human chronic phase, respec-
tively. These immune-neuroendocrine and metabolic changes are
highly relevant in evolutionary terms since they adjust the fine-tuning
of the protective response redirecting resources towards the establish-
ment of a well-balanced situation, which ultimately avoids an energy-
costly process. Such alterations may be a part of an adaptative immune-
neuroendocrine and metabolic regulatory circuitry tending to modulate
host defense or, alternatively, or secondary to disease-associated dys-
functions. Whatever the case, future studies will be needed to define
whether immune-neuroendocrine and metabolic alterations help to
shape the diverse manifestations of chronic Chagas disease. In addition
to its intrinsic value, this knowledge is critical when attempting to
delineate new intervention strategies for better control of disease and
their life-threatening disorders.
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